Five-Year Outcomes of the Tension-Free Vaginal Tape Procedure for Treatment of Female Stress Urinary Incontinence

Similar documents
Risk Factors of Voiding Dysfunction and Patient Satisfaction After Tension-free Vaginal Tape Procedure

Long-Term Outcome of the Tension-Free Vaginal Tape Procedure in Female Urinary Incontinence: A 6-Year Follow-Up

Resolution of urge urinary incontinence with midurethral sling surgery in patients with mixed incontinence and low-pressure urethra

Treatment Outcomes of Tension-free Vaginal Tape Insertion

Impact of the Midurethral Sling Procedure on Quality of Life in Women with Urinary Incontinence

Effect of Anesthesia on Voiding Function After Tension-Free Vaginal Tape Procedure

Incidence and Risk Factors of Postoperative De Novo Voiding Dysfunction following Midurethral Sling Procedures

Predictors of Postoperative Voiding Dysfunction following Transobsturator Sling Procedures in Patients with Stress Urinary Incontinence

Sequential Assessment of Urodynamic Findings before and aftertension-free Vaginal Tape (TVT) Operation for Female Genuine Stress Incontinence

Clinical Study Cough Test during Tension-Free Vaginal Tape Procedure in Preventing Postoperative Urinary Retention

Sdefined as involuntary urine leakage

Tension-free Vaginal Tape for Urodynamic Stress Incontinence

Intraoperative Observation of the Degree and Pattern of Urine Leakage before Adjustment of the Mesh during a Transobturator Tape Procedure

Urethral pressure measurement in stress incontinence: does it help?

To compare intermittent catheterization, sling mobilization and sling transection for treatment of

Influence of Obesity on Short-term Surgical Outcome of the Transobturator Tape Procedure in Patients with Stress Urinary Incontinence

Pelvic artery embolization in the management of pelvic arterial bleeding following midurethral sling surgery for stress urinary incontinence

A Simplified Urinary Incontinence Score for the Evaluation of Treatment Outcomes

Voiding Dysfunction. Yoo Jun Park, Duk Yoon Kim. INTRODUCTION

Urodynamics in women. Aims of Urodynamics in women. Why do Urodynamics?

How to Achieve Long-Term Success in the Treatment of Female Urinary Stress Incontinence? Novel Modification on Vaginal Sling

Efficacy and safety of a readjustable midurethral sling (Remeex system) for stress urinary incontinence with female voiding dysfunction

This information is intended as an overview only

Since the initial description of tension-free vaginal. Double Tension Adjustments with Novel Modification on Tension-Free Vaginal Tape INTRODUCTION

Urodynamic findings in women with insensible incontinence

The Suprapubic Arch Sling Procedure for Treatment of Stress Urinary Incontinence: A 5-Year Retrospective Study

The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence

Efficacy and Adverse Effects of Monarc Versus Tension-free Vaginal Tape Obturator: a Retrospective One-year Follow-up Study

The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (10), Page

Effects of the REMEEX System in Female Patients with Intrinsic Sphincteric Deficiency and Recurrent Urinary Incontinence: 3-Year Outcomes

Anatomical and Functional Results of Pelvic Organ Prolapse Mesh Repair: A Prospective Study of 105 Cases

PRE-OPERATIVE URODYNAMIC

SAFYRE TM : A READJUSTABLE MINIMALLY INVASIVE SLING FOR FEMALE URINARY STRESS INCONTINENCE

PUBOVAGINAL SLING IN THE TREATMENT OF STRESS URINARY INCONTINENCE FOR URETHRAL HYPERMOBILITY AND INTRINSIC SPHINCTERIC DEFICIENCY

Effect of Preoperative Flow Rate on Postoperative Retention and Voiding Difficulty After Transobturator Tape Operation

SPARC Sling System for Treatment of Female Stress Urinary Incontinence in the Elderly

Urogynecology Associates of Philadelphia URODYNAMIC TESTING

Operative Approach to Stress Incontinence. Goals of presentation. Preoperative evaluation: Urodynamic Testing? Michelle Y. Morrill, M.D.

Burch Colposuspension and Tension-Free Vaginal Tape in the Management of Stress Urinary Incontinence in Women

Repeat midurethral sling treatment for prior midurethral sling failure

READJUSTABLE SLING PROCEDURES FOR TREATMENT OF IN FEMALE STRESS URINARY INCONTINENCE WITH INTRINSIC SPHINCTER DEFICIENCY

Treatment of Female Stress Urinary Incontinence by Trans-Obturaror Tension-Free Vaginal Tape (TVT-O): A Prospecive Controlled Study

Efficacy and Safety of the TVT-SECUR R and Impact on Quality of Life in Women with Stress Urinary Incontinence: A 2-Year Follow-Up

Tension-free Vaginal Tape for the Treatment of Urodynamic Stress Incontinence: Efficacy and Adverse Effects at 10-Year Follow-Up

Transperineal ultrasound to assess the effect of tension-free vaginal tape position on flow rates

Original Article. Annals of Rehabilitation Medicine INTRODUCTION

AdVance Male Sling System

Randomized Clinical Trial Comparing Suprapubic Arch Sling (SPARC) and Tension-Free Vaginal Tape (TVT): One-Year Results

The Significance of Beaking Sign on Cystography in Stress Urinary Incontinence 1

Practical urodynamics What PA s need to know. Gary E. Lemack, MD Professor of Urology and Neurology

The Management of Female Urinary Incontinence. Part 1: Aetiology and Investigations

Tools for Evaluation. Urodynamics Case Studies. Case 1. Evaluation. Case 1. Bladder Diary SUI 19/01/2018

Comparison of midurethral sling outcomes with and without concomitant prolapse repair

Medical Review Criteria Invasive Treatment for Urinary Incontinence

Tension Free vaginal tape. Mrs Ami Shukla, Consultant Urogynaecologist Northampton General Hospital Northampton NN1 5BD

UroToday International Journal. Volume 3 - October 2010

Tension-Free Vaginal Taping in Pakistani Women with Stress Urinary Incontinence

INJ. Original Article INTRODUCTION. Int Neurourol J 2010;14: doi: /inj pissn eissn

Management of Female Stress Incontinence

q7:480499_P0 6/5/09 10:23 AM Page 1 WHAT YOU SHOULD KNOW ABOUT YOUR DIAGNOSIS OF STRESS URINARY INCONTINENCE

Midterm Prospective Evaluation of TVT-Secur Reveals High Failure Rate

Video-urodynamics. P J R Shah Institute of Urology and UCH

Kathleen C. Kobashi, MD, FACS Head, Section of Urology and Renal Transplantation Virginia Mason Medical Center, Seattle, WA

Female Urology Evaluation of Transobturator Tension-free Vaginal Tapes in Management of Women With Recurrent Stress Urinary Incontinence

Tension-Free Vaginal Tape versus Laparoscopic Bladder Neck Suspension for Stress Urinary Incontinence. Ching-Chung Liang, MD; Yung-Kuei Soong, MD

Analysis of voiding dysfunction after transobturator tape procedure for stress urinary incontinence

I-STOP TOMS Transobturator Male Sling

A PATIENT GUIDE TO Understanding Stress Urinary Incontinence

THE ACONTRACTILE BLADDER - FACT OR FICTION?

Seventeen years follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence

Comparison of Laparoscopic Burch and Tension-Free Vaginal Tape in Treating Stress Urinary Incontinence in Obese Patients

Medical Policy Title: Radiofrequency ARBenefits Approval: 10/19/2011

Int Urogynecol J (2010) 21: DOI /s ORIGINAL ARTICLE Experience with TVT-SECUR sling for stress urinary incontinence: a 1

Stress Urinary Incontinence in Women. What YOU can do about it...

Outcomes of Midurethral Slings in Women with Concomitant Preoperative Severe Lower Urinary Tract Voiding Symptoms

Urethrolysis; When, Why & How. M Karram Professor of Ob/Gyn & Urology University of Cincinnati

Adult Urodynamics: American Urological Association (AUA)/Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Guideline

Objective and Subjective Cure Rates after Trans-Obturator Tape (OBTAPE 1 ) Treatment of Female Urinary Incontinence

Prediction and prevention of stress urinary incontinence after prolapse surgery van der Ploeg, J.M.

Chapter 5. Steven E. Schraffordt Koops MD * Tanya M. Bisseling MD, PhD ** A. Peter M. Heintz MD, PhD *** Harry A.M.

New Insights in the Surgical Management of Stress Urinary Incontinence in Women

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

The Safety and Efficacy of a New Adjustable Single Incision Sling for Treatment of Female. Stress Urinary Incontinence Through 12-months of Follow-up

Is the role of Burch colposuspension fading away in this epoch for treating female urinary incontinence?

Prognostic value of urethral mobility and valsalva leak point pressure for female transobturator sling procedure

Role of bladder neck mobility and urethral closure pressure in predicting outcome of tension-free vaginal tape (TVT) procedure

Urodynamic study before and after radical porstatectomy 가톨릭의대성바오로병원김현우

Surgical management of stress urinary incontinence in Scotland and Wales: A questionnaire study

Sep \8958 Appell Dmochowski.ppt LMF 1

Recurrence rate of stress urinary incontinence in females with initial cure after transobturator tape procedure at 3-year follow-up

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Patients lost to follow-up after midurethral sling surgery: How are they?

Department of Obstetrics and Gynecology, Faculty of Medicine, Minia University, Minia, Egypt

Compassionate and effective management

FACTORS AFFECTING VOIDING FUNCTION IN UROGYNECOLOGY PATIENTS

TVT-O versus Monarc after a 2 4-year follow-up: a prospective comparative study

The Urethral Motion Profile Before and After Suburethral Sling Placement

Patient Information Leaflet

Desara TV and Desara Blue TV

INCONTINENCE AND OTHER UROLOGICAL DILEMMAS DR. ANNA LAWRENCE UROLOGIST AUCKLAND HOSPITAL 161 UROLOGY

Transcription:

european urology 50 (2006) 333 338 available at www.sciencedirect.com journal homepage: www.europeanurology.com Female Urology Incontinence Five-Year Outcomes of the Tension-Free Vaginal Tape Procedure for Treatment of Female Stress Urinary Incontinence Chin Kyung Doo a, Bumsik Hong a, Byung Joo Chung b, Ji Yoon Kim c, Hee Chang Jung c, Kyu-Sung Lee b, Myung-Soo Choo a, * a Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea b Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea c Department of Urology, Yeungnam University Hospital, Daegu, Korea Article info Article history: Accepted April 18, 2006 Published online ahead of print on May 2, 2006 Keywords: Outcomes Prostheses and implants Stress urinary incontinence Tension-free vaginal tape Urinary incontinence Vagina Please visit www.eu-acme.org to read and answer the EU-ACME questions on-line. The EU-ACME credits will then be attributed automatically. Abstract Objectives: We evaluated the long-term efficacy and safety of a tension-free vaginal tape (TVT) procedure for the treatment of female stress urinary incontinence (SUI) in a Korean population. Methods: We included 134 patients (mean age, 52.3 9.3 yr) who underwent the TVT procedure for SUI in three institutions and followed for 5 yr (mean, 67.0 mo; range, 60 76 mo) postoperatively. We analysed voiding diaries and complete multichannel urodynamic studies preoperatively as well as cough stress tests, uroflowmetry, and questionnaires postoperatively. Results: The overall 5-yr success rates (cure/improved) were 94.9% (76.9% and 18.0%, respectively), with an 86.6% patient satisfaction rate. Although the success rates between 1 and 5 yr were similar (97.7% vs. 94.9%), the cure rate decreased from 90.1% to 76.9% ( p < 0.001) at 5 yr. The 5-yr cure rate for mixed urinary incontinence (MUI) was 72.0%, which was not significantly different from pure SUI (78.0%, p > 0.05). Maximal flow rate dropped from 25.9 10.3 ml/s to 20.4 8.6 ml/s at 1 mo postoperatively and recovered to 24.8 8.5 ml/s at 5 yr. Complications included bladder perforation in 5 patients (3.7%), tape cutting or release in 11 (8.2%), and persistent suprapubic pain in 3 (2.2%). Urgency and urge incontinence improved in 46.7% and 48.0% of patients, respectively. Conclusions: TVT was an effective and safe procedure for SUI and MUI with high success rates in the long-term follow-up. It also improved concomitant overactive bladder symptoms and initially reduced postoperative urine flow, which recovered over time. # 2006 European Association of Urology. Published by Elsevier B.V. All rights reserved. * Corresponding author. Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-dong, Songpa-gu, 138-736 Seoul, Korea. Tel. +82 2 301 3735; Fax: +82 2 477 8928. E-mail address: mschoo@amc.seoul.kr (M.S. Choo). 0302-2838/$ see back matter # 2006 European Association of Urology. Published by Elsevier B.V. All rights reserved. doi:10.1016/j.eururo.2006.04.007

334 european urology 50 (2006) 333 338 1. Introduction The tension-free vaginal tape (TVT) procedure, first described in 1996, is a modified suburethral sling procedure for female stress urinary incontinence (SUI) based on the integral theory [1]. The TVT procedure has become the treatment of choice for SUI because it is a minimally invasive operation with high success rates after short- and intermediateterm follow-up [2,3]. Few long-term follow-up data on the TVT procedure are availabe, however, except from Scandinavian groups, who pioneered this method. Furthermore, no long-term data on the TVT procedure are available from Asian countries. We therefore evaluated the long-term efficacy and safety of the TVT procedure, with a follow-up of >5 yr, for the treatment of female SUI. 2. Methods Between March 1999 and June 2000, 155 consecutive women with complaints of SUI underwent the TVT procedure in three institutions in Korea. Among these patients, 138 were followed up for at least 5 yr; the remaining 17 patients could not be followed up because they did not respond when contacted by mail and telephone. In 138 patients, 4 who underwent concomitant surgery (hysterectomy in 1, caruncle excision in 1, and cystocele repair in 2) were excluded from the evaluation because those procedures might have influenced the cure rates. The 134 patients studied had a mean age of 52.3 9.3 yr (mean follow-up period, 67.0 mo; range, 60 76 mo). Preoperative evaluations included medical history, physical examination, 3-d voiding diary, uroflowmetry, postvoid residual urine measurement, and complete multichannel urodynamic investigation. Urodynamic evaluation consisted of filling and voiding cystometry, Valsalva leak point pressure (VLPP), and maximal urethral closing pressure (MUCP) measurements. Nonintubated urine flow rates were obtained using an MMS flowstar calibrated by trained study assistants. Electronically measured peak urinary flow rates, average flow rates, and voided volume were determined. Measurements were repeated if voided volume was <150 ml. In cases of duplicate measurements, we used the highest rate in our analyses. Using the Aquarius 120, filling cystometry was performed at a rate of 100 ml/min using sterile saline with the subject seated in a chair. A 6F doublelumen cystometry catheter was placed into the urethra and bladder. When the patient felt a maximal desire to void, she was asked to void. During the voiding phase the intravesical pressure, detrusor pressure, abdominal pressure, flow rate, and detrusor pressure at maximal flow rate were recorded. VLPP was obtained at a bladder volume of 200 ml by asking the patients to perform a Valsalva maneuver until leakage occurred. MUCP was measured by withdrawing the intravesical catheter at a rate of 1 m/min to create a urethral pressure profile and calculated by subtracting the baseline bladder pressure from the maximal urethral pressure. All definitions corresponded to those of the International Continence Society [4]. The TVT procedure was performed by experienced surgeons using the standard technique with some modifications [1]. The operations were usually performed using a combination of light sedation and local anaesthesia but generalorspinalanaesthesiawasusedifrequestedbythe patient or when concomitant pelvic or vaginal procedures were performed. All patients visited the clinics 1 yr and 5 yr after surgery, at which time they were again evaluated by a medical history, physical examination, uroflowmetry, and postvoid residual urine measurement. A patient global satisfaction was assessed at 5 yr. We analysed the success rates of TVT for treatment of SUI and mixed urinary incontinence (MUI), patients perception of satisfaction, changes in overactive bladder symptoms after surgery, and complications related to surgery. Cure was defined as the absence of any episodes of involuntary urine leakage during the stressful activities and stress cough test. Improvement was defined as a significant reduction of urine leakage, such that it did not require further treatment [5]. All other outcomes were regarded as failures. Patient perception of this operation was categorised as very satisfied, satisfied, so-so, and dissatisfied, with both very satisfied and satisfied scored as satisfied. Safety data were collected during the entire follow-up period. Urgency was defined as a sudden compelling desire to pass urine, which was difficult to defer and urge incontinence was defined as involuntary leakage accompanied by or immediately preceded by urgency [4]. Normally distributed variables were compared with the Student t test. A 5% level of significance was used for all statistical testing and all statistical tests were 2-sided. Analyses were performed using statistical software (SPSS 11.0, SPSS, Chicago, IL). 3. Results Table 1 shows the characteristics of the 134 patients. The mean parity of these patients was 3.2 1.6, and their mean body mass index (BMI) was 24.2 2.7 kg/m 2. Seventeen (12.7%) of these patients had previously undergone hysterectomy. Before surgery, 25 (18.7%) of the women complained of concomitant urge incontinence and 30 (22.4%) complained of urgency. Preoperative symptom grade was 1 (loss of urine only with coughing, sneezing, or lifting heavy objects) in 66 (47.8%) patients, 2 (loss of urine with minimal activity such as walking or standing from the sitting position) in 63 (47.0%), and 3 (totally incontinent while upright) in 5 (3.7%). Seven (5.2%) patients had previously undergone anti-incontinence surgery, including the Raz procedure, anterior vaginal wall sling, or bladder-neck suspension. Sixty-eight (50.7%) patients underwent TVT under local anaesthesia,

european urology 50 (2006) 333 338 335 Table 1 Characteristics of 138 patients Mean age, yr (range) 52.3 (35 78) Mean parity (range) 3.2 (0 10) Mean body mass index, kg/m 2 (range) 24.2 (17 31) No. grade 2 cystocele (%) 6 (4.5%) No. associated urge incontinence (%) 25 (18.7%) No. urgency (%) 30 (22.4%) No. concomitant posterior repair (%) 11 (8.2%) No. SUI grade (%) 1 66 (47.8%) 2 63 (47.0%) 3 5 (3.7%) Mean 1-h pad test, g(range) 45.8 (5 500) Mean urodynamic parameters: Peak urinary flow, ml/s (range) 25.8 (5 71) Voided volume, ml (range) 292.4 (55 578) Post-voided residual, ml (range) 13.6 (0 79) Maximum cystometric capacity, ml (range) 434.6 (220 652) Maximum detrusor pressure, cm H 2 O (range) 28.5 (10 76) VLPP, cm H 2 O (range) 79.5 (22 194) MUCP, cm H 2 O (range) 53.3 (9 113) No. detrusor overactivity (%) 32 (23.9%) Mean functional bladder capacity, ml (range) 372.9 (200 600) No. anaesthesia (%) Local 68 (50.7%) Spinal 42 (31.3%) General 24 (17.9%) SUI = stress urinary incontinence; VLPP = Valsalva leak point pressure; MUCP = maximal urethral closing pressure. whereas 42 (31.3%) and 24 (17.9%) chose spinal and general anaesthesia, respectively. Mean operative time was 28.3 min (range, 17 100 min). Mean hospital stay was 2.1 d (range, 0 13 d) and mean urethral catheter indwelling time was 0.8 d (range, 0 6 d). The success rates in these 134 women are presented in Table 2. The overall 1-yr cure and improvement rates were 90.1% (118 of 131) and 7.6% (10 of 131); treatment failed in three patients (2.3%). The overall 5-yr cure, improvement, and failure rates were 76.9% (103 of 134), 18.0% (24 of 134), Table 3 The 1- and 5-yr outcomes of tension-free vaginal tape for mixed urinary incontinence 1yr 5yr Cure * Cure * Satisfaction MUI + 83.3 (20/24) 72.0 (18/25) 80.0 (20/25) 91.6 (98/107) 78.0 (85/109) 88.1 (96/109) p 0.256 0.600 0.329 * p < 0.05. and 5.2% (7 of 134), respectively. Although the 1- and 5-yr success rates were similar (97.7% vs. 94.9%), the cure rate of the TVT procedure decreased significantly over time (90.1% vs. 76.9%, p < 0.001). A total of 116 (86.6%) women were satisfied with the operation. The 1-yr cure rate of TVT for MUI was 83.3% (20 of 24), which was not significantly different from the 1- yr cure rate for pure SUI (98 of 107, 91.6%; p > 0.05). The 5-yr cure rate (18 of 25, 72.0%) for MUI also did not differ significantly from the 5-yr cure rate for pure SUI (85 of 109, 78.0%; p > 0.05). Twenty patients (80.0%) with MUI and 96 (88.1%) with pure SUI were satisfied with the operation ( p > 0.05, Table 3). The overall 5-yr cure rate of patients with VLPP <60 cm H 2 O was 50.0% (15 of 30), which was significantly lower than that of patients with VLPP 60 cm H 2 O (51 of 61, 83.6%, p = 0.001). When we divided the patients into three groups according to symptom grade, we found that the cure rates were 87.9% (58 of 66) in women with grade 1, 68.3% (43 of 63) in women with grade 2, and 40% (2 of 5) in women with grade 3 ( p = 0.004; Fig. 1). The mean maximal flow rate before the TVT procedure was 25.9 10.3 ml/s, but decreased significantly to 20.4 8.6 ml/s at 1 mo after the operation ( p < 0.001). Over time, however, the urinary flow rate increased linearly, with the maximal flow rate Table 2 The 1- and 5-yr outcomes of tension-free vaginal tape for stress urinary incontinence Outcome 1 yr 5 yr Success * Cured 90.1% (118/131) 76.9% (103/134) Improved 7.6% (10/131) 18.0% (24/134) Failed 2.3% (3/131) 5.2% (7/134) Satisfaction Satisfied 86.6% (116/134) Equivocal 5.2% (7/134) Unsatisfied 8.2% (11/134) * p < 0.05. Fig. 1 Success rates relative to Valsalva leak point pressure (VLPP) and stress urinary incontinence (SUI) grade.

336 european urology 50 (2006) 333 338 Table 4 Complications after tension-free vaginal tape procedure No. (%) Bladder perforation 5 (3.7%) Recurrent urinary tract infection 2 (1.5%) Short-term voiding difficulty 8 (6.0%) (indwelling catheter for 2 6 d) De novo urgency 16 (15.4%) Tension-free vaginal tape release or cutting 11 (8.2%) Persistent pain on suprapubic area 3 (2.2%) Clean intermittent catheterisation 1 (0.7%) Weakness in both legs 1 (0.7%) 4. Discussion Fig. 2 Change in uroflowmetry parameters over time. MFR = maximal flow rate; PVR = postvoided residual. * p < 0.05 compared to preoperative. y p > 0.05 compared to preoperative. 5 yr after surgery increasing to 24.8 8.5 ml/s, which was similar to the preoperative flow rate. In contrast, the postvoid residual urine increased significantly, to 30.0 47.1 ml (Fig. 2). Compared with preoperative levels, a significant decrease was reported in micturition frequency per day (7.1 1.8 to 6.5 1.7, p = 0.004), but no significant change in patients with MUI (8.6 1.7 to 7.6 2.7, p = 0.248) over 5 yr. Functional bladder capacity did not change (358.9 86.6 ml to 343.7 91.3 ml, p = 0.460). Urgency and urge incontinence improved in 46.7% (14 of 30) and 48.0% (12 of 25) of patients, respectively. However, 11.5% (12 of 104) developed de novo urgency and urge incontinence, and another 3.8% (4 of 104) developed de novo urgency. Patients with persistent (n = 16) or de novo (n = 16) overactive bladder symptoms were managed with anticholinergics. Five (3.7%) patients had a bladder perforation, which was managed with an indwelling urinary catheter for 1 3 d. Eight (6.0%) women had urinary retention after surgery. Short-term retention was treated with an indwelling catheter for 2 6 d. Two patients experienced recurrent urinary tract infection, and one patient required clean intermittent catheterisation due to voiding dysfunction. Eleven (8.2%) patients underwent a simple vaginal TVT release or incision procedure because of reduced stream and large amounts of residual urine. Three (2.2%) patients complained of persistent pain on the suprapubic area. There were no bowel, nerve, or major vessel injuries, and no vaginal or urethral erosion was identified (Table 4). A Scandinavian group published 7-yr (mean, 91.9 mo) follow-up data of the TVT procedure in 80 patients. Results showed that both objective (negative stress test and <8 g in 24-h pad-weighing test) and subjective (completely dry) cure rates were 81.3% [6]. To our knowledge, there is only one longterm report on TVT other than this Scandinavian one [7]. Of the 52 patients who were followed for a mean of 55 mo, 41 (78.9%) were dry, indicating that the TVT procedure was safe and effective, making this technique the optimal surgical treatment for female SUI. In patients followed for a minimum of 5 yr, we found that the success (cured and improved) rate was maintained from 97.7% at 1 yr to 94.9% at 5 yr. Interestingly, although the success rate remained constant, the cure rate decreased significantly over time. A poor correlation was found between quality of life impairment and the cure [8], which could explain that our satisfaction rate was higher than the cure at the same time. The success rates of the TVT procedure in women with MUI, however, are not consistent. In one study, the overall subjective cure rate at 6 mo was 91%, whereas a subgroup with MUI had a cure rate of 89% [9]. In contrast, a second study found that patients with SUI had a persistent cure rate of 85% from 2 to 8 yr after surgery, whereas the cure rate of patients with MUI steadily declined to 30% from 4 to 8 yr after surgery [10]. In our study, the 5-yr postoperative cure rate of patients with MUI was 72.0%, not significantly different from that of patients with pure SUI (78.0%). The small difference observed may have been due to the small numbers of patients with MUI,indicatinganeedforastudyinalargernumber of patients with MUI. At present, the measurement of intrinsic sphincter deficiency has not been standardised. However, MUCP <20 cm H 2 OorVLPP<60 cm H 2 O have been the urodynamic criteria for the diagnosis of intrinsic sphincter deficiency [11]. According to Paick et al. the

european urology 50 (2006) 333 338 337 overall cure rate of TVT 10 mo after surgery was significantly lower in patients with low VLPP (<60 cm H 2 O) than in those with higher VLPP (60 cm H 2 O; 82.0% vs. 93.1%) [12]. Our study confirmed this result. However, data on the success of the SUI symptom grade are sparse. In one report on factors for the cure of TVT, preoperative symptom grade was not associated with the cure rate of the operation [13]. In contrast, we found that high incontinence grade may impair the efficacy of the TVT procedure. Voiding dysfunction following anti-incontinence surgery is not uncommon. Although the TVT procedure makes a dynamic urethral kinking without compressing the urethra at rest [14], 2.8 14% of patients later develop obstructive voiding symptoms [15]. Using univariate and multivariate analysis, we previously found that only maximal flow rate could predict women at risk for postoperative urinary retention [16]. Both urethra and TVT tape are thought likely to exhibit the same downward displacement, resulting in a mechanical obstruction similar to that observed on the Valsalva maneuver. In evaluating uroflowmetry indices and voiding symptoms after TVT placement, there was a significant increase in maximal flow rate percentile, whereas postvoid residual urine volume decreased significantly in patients measured at least twice after surgery [17]. This may have been due to a slow downward displacement of the tape and surrounding tissues, which resulted in less marked urethral compression, or to chronic obstruction resulting in progressive detrusor hypertrophy and allowing better emptying function. In another study with follow-up of multichannel urodynamic study, the mean preoperative values of average flow rate, maximal flow rate, postvoided residual urine volume, and the detrusor pressure at peak flow during voiding cystometry showed no significant differences compared with values at 3, 6, and 12 mo after TVT operation [18].We found that the maximal flow rate decreased significantly after surgery, but, during the 5-yr follow-up period, it increased linearly, up to preoperative levels. Although postvoid residual urine volume increased permanently during the same follow-up period, it was <30 ml, which was not significant clinically. We also found, 5 yr after surgery, the mean maximal flow rate and postvoid residual urine volume of completely dry women were similar to those of women showing improvement or failure and that it showed a pattern similar to those shown by overall maximal flow rate and postvoid residual. These findings suggest that the voiding function after the TVT procedure is not related to the cure rate of this surgery. Bladder perforation is one of the most frequently observed complications after the TVT procedure, estimated to occur in 5.8% of women [19]. We observed a similar rate (3.7%; 5 of 134 patients), although most of these patients needed an indwelling catheter for a short period of time. In addition, 11 patients (8.2%) underwent TVT release or incision due to long-term voiding dysfunction after surgery, a rate somewhat higher than that recently reported (2%) [20]. In our experience, the anxiety over urinary continence and the cough stress test during the procedure soon after the introduction of the TVT procedure to our country results in the application of unnecessary tension to the sling. Rardin et al. reported that of 23 patients who underwent the TVT release procedure, 14 (61%) remained continent and 3 (13%) had recurrence of stress incontinence [20]. Of the 11 patients in this study with TVT release or incision, 9 (81.8%) were completely dry at 5 yr postoperatively, whereas only 1 (9.1%) returned to the preoperative stress incontinence state. In an analysis of the changes in urge incontinence and overactive bladder symptoms after the TVT procedure at a mean follow-up of 7.1 8.1 mo, 4.3% and 9.1% of patients with pure SUI had developed de novo urgency and de novo incontinence, respectively [21]. Of the patients with MUI, the urge component resolved in 63.1%, whereas preoperative overactive bladder symptoms resolved in 57.3% of patients after the TVT procedure. In our study, at 5 yr after surgery, 11.5% of patients complained of de novo urgency and urge incontinence, and another 3.8% complained of de novo urgency. In contrast, preoperative urgency and urge incontinence improved in 46.7% and 48.0% of patients, respectively. Thus, the proportion of patients who developed de novo urgency or urge incontinence postoperatively was relatively low compared to improvement rates of overactive symptoms that resolved after surgery. 5. Conclusions The high long-term success rate of the TVT procedure shows that this surgery is effective and safe for the treatment of SUI and MUI. The TVT procedure may have an obstructive effect on voiding and may reduce maximal flow rate, which improves over time. Concomitant overactive bladder symptoms also improved in many patients. References [1] Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1996;7:81 5.

338 european urology 50 (2006) 333 338 [2] Ulmsten U, Johnson P, Rezapour M. A three-year follow up of tension free vaginal tape for surgical treatment of female stress urinary incontinence. Br J Obstet Gynaecol 1999;106:345 50. [3] Nilsson CG, Kuuva N, Falconer C, Rezapour M, Ulmsten U. Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:S5 8. [4] Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003;61:37 49. [5] Stamey TA. Endoscopic suspension of the vesical neck for urinary incontinence in females. Report on 203 consecutive patients. Ann Surg 1980;192:465 71. [6] Nilsson CG, Falconer C, Rezapour M. Seven-year followup of the tension-free vaginal tape procedure for treatment of urinary incontinence. Obstet Gynecol 2004;104: 1259 62. [7] Tsivian A, Mogutin B, Kessler O, Korczak D, Levin S, Sidi AA. Tension-free vaginal tape procedure for the treatment of female stress urinary incontinence: long-term results. J Urol 2004;172:998 1000. [8] Munir N, Bunce C, Gelister J, Briggs T. Outcome following TVT sling procedure: a comparison of outcome recorded by surgeons to that reported by their patients at a London district general hospital. Eur Urol 2005;47:635 40. [9] Abdel-Hady el-s, Constantine G. Outcome of the use of tension-free vaginal tape in women with mixed urinary incontinence, previous failed surgery, or low Valsalva pressure. J Obstet Gynaecol Res 2005;31:38 42. [10] Holmgren C, Nilsson S, Lanner L, Hellberg D. Long-term results with tension-free vaginal tape on mixed and stress urinary incontinence. Obstet Gynecol 2005;106:38 43. [11] McGuire EJ, Lytton B, Pepe V, Kohorn EI. Stress urinary incontinence. Obstet Gynecol 1976;47:255 64. [12] Paick JS, Ku JH, Shin JW, Son H, Oh SJ, Kim SW. Tensionfree vaginal tape procedure for urinary incontinence with low Valsalva leak point pressure. J Urol 2004;172:1370 3. [13] Cetinel B, Demirkesen O, Onal B, Akkus E, Alan C, Can G. Are there any factors predicting the cure and complication rates of tension-free vaginal tape? Int Urogynecol J Pelvic Floor Dysfunct 2004;15:188 93. [14] Lo TS, Wang AC, Horng SG, Liang CC, Soong YK. Ultrasonographic and urodynamic evaluation after tension free vagina tape procedure (TVT). Acta Obstet Gynecol Scand 2001;80:65 70. [15] Klutke C, Siegel S, Carlin B, Paszkiewicz E, Kirkemo A, Klutke J. Urinary retention after tension-free vaginal tape procedure: incidence and treatment. Urology 2001;58:697 701. [16] Hong B, Park S, Kim HS, Choo MS. Factors predictive of urinary retention after a tension-free vaginal tape procedure for female stress urinary incontinence. J Urol 2003;170:852 6. [17] Dietz HP, Ellis G, Wilson PD, Herbison P. Voiding function after tension-free vaginal tape: a longitudinal study. Aust N Z J Obstet Gynaecol 2004;44:152 5. [18] Lin LY, Sheu BC, Lin HH. Sequential assessment of urodynamic findings before and after tension-free vaginal tape (TVT) operation for female genuine stress incontinence. Eur Urol 2004;45:362 6. [19] Abouassaly R, Steinberg JR, Lemieux M, et al. Complications of tension-free vaginal tape surgery: a multi-institutional review. BJU Int 2004;94:110 3. [20] Rardin CR, Rosenblatt PL, Kohli N, Miklos JR, Heit M, Lucente VR. Release of tension-free vaginal tape for the treatment of refractory postoperative voiding dysfunction. Obstet Gynecol 2002;100:898 902. [21] Segal JL, Vassallo B, Kleeman S, Silva WA, Karram MM. Prevalence of persistent and de novo overactive bladder symptoms after the tension-free vaginal tape. Obstet Gynecol 2004;104:1263 9.